ResearcherHarvard UniversityActive in the last 2 years
Lestat R. Ali
Matched on ORCID iD 0000-0003-2673-1592; OpenAlex author ID A5041054069. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 42
2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 4
- Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2026.04.005↗
- PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-23-1444↗
- Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the T… Co-author DOI 10.1158/2326-6066.cir-23-1073↗
- Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy. Co-author DOI 10.1053/j.gastro.2023.05.038↗
Closest collaborators
The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Victoire Cardot‐Ruffino · 4 shared papers, 2023–2026 · strength 0.63
- Paper Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. DOI 10.1016/j.ccell.2026.04.005↗
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy. DOI 10.1053/j.gastro.2023.05.038↗
- Stephanie K. Dougan · 4 shared papers, 2023–2026 · strength 0.63
- Paper Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. DOI 10.1016/j.ccell.2026.04.005↗
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy. DOI 10.1053/j.gastro.2023.05.038↗
- Brian Matthew Wolpin · 3 shared papers, 2024–2026 · strength 0.49
- Paper Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. DOI 10.1016/j.ccell.2026.04.005↗
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Jonathan Andrew Nowak · 3 shared papers, 2024–2026 · strength 0.49
- Paper Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. DOI 10.1016/j.ccell.2026.04.005↗
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Michael Lawrence Dougan · 3 shared papers, 2023–2026 · strength 0.47
- Paper Dendritic cell redundancy enables priming of anti-tumor CD4+ T cells in pancreatic cancer. DOI 10.1016/j.ccell.2026.04.005↗
- Paper Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy. DOI 10.1053/j.gastro.2023.05.038↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Thomas E. Clancy · 2 shared papers, 2024–2026 · strength 0.35
- Joseph Douglas Mancias · 2 shared papers, 2024–2026 · strength 0.35
- Harshabad Singh · 2 shared papers, 2024–2026 · strength 0.33
- Douglas Adam Rubinson · 2 shared papers, 2024–2026 · strength 0.33
- Brandon M. Huffman · 2 shared papers, 2024–2026 · strength 0.33
- Kimberly J. Perez · 2 shared papers, 2024–2026 · strength 0.33
- James M. Cleary · 2 shared papers, 2024–2026 · strength 0.33
- Andressa Dias Costa · 2 shared papers, 2024 · strength 0.30
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Thomas Adam Abrams · 2 shared papers, 2024 · strength 0.30
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Osama E. Rahma · 2 shared papers, 2024 · strength 0.30
- Paper PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with … DOI 10.1158/1078-0432.ccr-23-1444↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Marc R. Pelletier · 2 shared papers, 2023–2024 · strength 0.28
- Paper Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy. DOI 10.1053/j.gastro.2023.05.038↗
- Paper Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Ca… DOI 10.1158/2326-6066.cir-23-1073↗
- Courtney T.S. Kureshi · 1 shared paper, 2026 · strength 0.19
- Chong Zuo · 1 shared paper, 2026 · strength 0.19
- George Molina · 1 shared paper, 2026 · strength 0.19
- Sarah Slater · 1 shared paper, 2026 · strength 0.19
- Craig Lee Slingluff · 1 shared paper, 2024 · strength 0.16
- Matthew H. G. Katz · 1 shared paper, 2024 · strength 0.16
- Jiping Wang · 1 shared paper, 2024 · strength 0.16
- Chee‐Chee Stucky · 1 shared paper, 2024 · strength 0.16
- Rawad Elias · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.